Filter
2013
Filtered Results: 2013
Text search:
health
recipient
Featured
Recommendations
171
New Publications
503
Language
Document type
No document type
1069
Guidelines
333
Studies & Reports
315
Manuals
126
Strategic & Response Plan
63
Fact sheets
46
Training Material
32
Situation Updates
13
Resource Platforms
7
Infographics
6
Online Courses
2
Brochures
1
Countries / Regions
Global
110
India
55
Latin America and the Carribbean
47
Kenya
41
South Africa
40
Western and Central Europe
35
Nepal
33
Myanmar / Burma
30
Mozambique
28
Ethiopia
27
Uganda
27
Liberia
26
Nigeria
26
Brazil
26
Senegal
24
Tanzania
24
Malawi
24
Sierra Leone
23
Ukraine
23
Colombia
22
Africa
22
Zambia
21
Congo, Democratic Republic of
20
Bangladesh
20
Rwanda
19
Syria
18
Paraguay
18
Philippines
17
Venezuela
17
Eastern Europe
16
Ghana
14
Haiti
13
Namibia
12
Guinea
11
Cambodia
11
Asia
11
Burkina Faso
10
Zimbabwe
10
Peru
10
Lesotho
10
Indonesia
9
Argentina
9
Ecuador
9
Angola
9
Cameroon
8
Pakistan
8
Germany
8
Bolivia
8
West and Central Africa
8
South–East Asia Region
8
Mali
7
Côte d’Ivoire / Ivory Coast
6
Benin
6
Botswana
6
Chile
6
Yemen
6
East and Southern Africa
6
Middle East and North Africa
6
South Sudan
5
Thailand
5
China
5
Western Pacific Region
5
Russia
5
Moldova
5
Guinea-Bissau
4
Central African Republic
4
Eswatini/ Swaziland
4
Madagascar
4
Sri Lanka
4
Albania
4
Tajikistan
4
Vietnam
4
Niger
3
Jordan
3
Lebanon
3
Chad
3
Sudan
3
North Macedonia
3
Eastern Europe and Central Asia
3
Bhutan
3
Laos
3
Spain
3
Togo
2
Afghanistan
2
El Salvador
2
Palestine
2
Canada
2
Georgia
2
USA
1
Somalia
1
Iraq
1
Malaysia
1
Singapore
1
Dominican Republic
1
Switzerland
1
Burundi
1
Libya
1
Guatemala
1
Fiji
1
Armenia
1
Southern Africa
1
Lithuania
1
Kyrgyzstan
1
Kazakhstan
1
Japan
1
Mauritius
1
United Kingdom
1
Portugal
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
664
Clinical Guidelines
143
Key Resources
131
Public Health
94
Women & Child Health
83
Pharmacy & Technologies
38
Capacity Building
30
Annual Report MEDBOX
1
Toolboxes
COVID-19
270
HIV
143
TB
112
Mental Health
102
Disability
101
Health Financing Toolbox
91
Rapid Response
74
Pharmacy
56
Caregiver
54
NTDs
50
Planetary Health
49
Ebola
45
Conflict
43
Refugee
41
Natural Hazards
33
AMR
33
Global Health Education
31
Zika
21
Cholera
14
Social Ethics
14
Polio
11
NCDs
11
Specific Hazards
4
Typhoon
2
Health Financing
2
Annex 5, WHO Technical Report Series 1010, 2018
9 Febr. 2022
The COVID Covovax™ (SIIPL) and Nuvaxovid™ (Novavax) vaccine explainer includes key vaccine specific information on the vaccine specific requirements.
A rapid evidence briefing. Vaccinated people are less likely to develop long COVID, even if they get infected, a rapid review of 15 studies by the UK Health Security Agency shows.
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pand...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and ...
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
The Transformation Agenda (TA) ushered in an ambitious reform process intended to transform the World Health Organization (WHO) into an organization that is proactive, results-driven, accountable and which meets stakeholder expectations, towards tra...
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
Between 2012 and 2016, development assistance for HIV/AIDS decreased by 20·0%; domestic financing is therefore critical to sustaining the response to HIV/AIDS. To understand whether domestic resources could fill the financing gaps created by declines in development assistance, we aimed to track spe...
The document, "Sustainable Management of Radiotherapy Facilities and Equipment," by WHO and IAEA, provides guidelines for managing radiotherapy equipment and facilities to ensure effective and safe cancer treatment. It covers essential aspects like preventive and corrective maintenance, funding, inf...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and ... systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
